Dabur, Ferns N Petals and Lotte India correct labelling and advertising lapses after FSSAI notices

FSSAI said the companies have acted on notices covering product classification, labels and advertising claims. Dabur relisted an oil product as Ayurvedic medicine, while other firms revised labels or removed and corrected claims.

— Source published Tue, 18 Aug, 2026, 23:40 IST · First seen Tue, 18 Aug, 2026, 23:58 IST · Source ET Small Business

What happened

Dabur India · FSSAI said Dabur, Ferns N Petals and Lotte India corrected labelling, classification and advertising lapses after regulatory notices. Actions

Key facts

  • 100%

Why this matters

Acquirers should intensify regulatory diligence on product classifications, packaging claims and advertising substantiation before valuing FMCG targets.

What to watch

  • Additional FSSAI notices, penalties, product withdrawals, or public naming of brands in adjacent FMCG categories.
  • Formal FSSAI guidance on classification boundaries between food products, nutraceuticals, Ayurvedic medicines, and cosmetic or personal-care products.
  • Advertising Standards Council of India actions against health, immunity, therapeutic, or misleading natural-product claims.
  • Rising frequency of packaging changes, e-commerce listing edits, or discontinued SKUs among consumer brands.
  • Consumer complaints, retailer queries, or social-media scrutiny linking claim corrections to product safety or efficacy concerns.
  • Audit product classifications, ingredient declarations, mandatory label disclosures, and substantiation files for all health, wellness, natural, immunity, digestive, and therapeutic claims.
  • Pause or revise ambiguous advertising copy across packaging, e-commerce listings, quick-commerce product pages, social media, and influencer briefs.
  • Prepare relabelling inventory plans to minimize write-offs and retailer delistings if packaging changes are mandated.
  • Increase legal-regulatory review of products positioned between food, supplements, Ayurvedic medicine, and cosmetics.
  • Use corrected claims to build a compliance narrative with trade partners and consumers before competitors frame the issue as a trust deficit.